A Phase III Study of Remimazolam in Patients Undergoing Bronchoscopy
Status:
Completed
Trial end date:
2017-03-13
Target enrollment:
Participant gender:
Summary
A prospective, double-blind, randomized, placebo and active controlled, multi-center,
parallel group study comparing remimazolam to placebo, with an additional open label arm for
midazolam, in patients undergoing a bronchoscopy.